We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Accelrys and Agilent Technologies Enter into Comprehensive Resale Agreement

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Accelrys and Agilent Technologies Enter into Comprehensive Resale Agreement"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Accelrys Inc. and Agilent Technologies Inc. announced they have entered into a comprehensive resale agreement to enable the licensing and integration of their informatics products. The partnership covers the breadth of informatics portfolios of both companies and will enable customers in the pharmaceutical industry to enjoy unprecedented integration of laboratory data, experimental results and insights across the enterprise.

“This partnership will enable unparalleled integration of informatics products,” said Bruce von Herrmann, Agilent vice president and general manager, Informatics Division. “It will significantly benefit pharmaceutical companies that want to spend less time integrating existing informatics solutions and more time developing new, more effective medicines.”

Agilent and Accelrys will offer compatible and enhanced solutions incorporating their respective portfolios of informatics products. Accelrys will resell OpenLAB Enterprise Content Manager, Kalabie Electronic Lab Notebook, and GeneSpring gene expression solutions. Agilent will resell Accord cheminformatics solutions and Pipeline Pilot Scientific Operating Platform solutions.